DOV vs MIST · P/E 27, rev $4.24B vs rev $797.0K
Dover Corporation (DOV) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. MIST currently screens at market cap $160.6M.
Not investment advice. Open the DOV and MIST stock pages for the full models.
Not investment advice.